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Abstract
The objective of this work was to fabricate a rigid, resorbable and osteoconductive scaffold by
mimicking the hierarchical structure of the cortical bone. Aligned peptide-functionalize nanofiber
microsheets were generated with calcium phosphate (CaP) content similar to that of the natural
cortical bone. Next, the CaP-rich fibrous microsheets were wrapped around a microneedle to form
a laminated microtube mimicking the structure of an osteon. Then, a set of the osteon-mimetic
microtubes were assembled around a solid rod and the assembly was annealed to fuse the micro-
tubes and form a shell. Next, an array of circular microholes were drilled on the outer surface of
the shell to generate a cortical bone-like scaffold with an interconnected network of Haversian- and
Volkmann-like microcanals. The CaP content, porosity and density of the bone-mimetic micro-
sheets were 240 wt%, 8% and 1.9 g/ml, respectively, which were close to that of natural cortical
bone. The interconnected network of microcanals in the fused microtubes increased permeability
of a model protein in the scaffold. The cortical scaffold induced osteogenesis and vasculogenesis
in the absence of bone morphogenetic proteins upon seeding with human mesenchymal stem cells
and endothelial colony-forming cells. The localized and timed-release of morphogenetic factors
significantly increased the extent of osteogenic and vasculogenic differentiation of human mesen-
chymal stem cells and endothelial colony-forming cells in the cortical scaffold. The cortical bone-
mimetic nature of the cellular construct provided balanced rigidity, resorption rate, osteoconductiv-
ity and nutrient diffusivity to support vascularization and osteogenesis.
Keywords: bone regeneration; cortical bone-like; osteon-mimetic; calcium phosphate nucleated nanofiber microsheet; vascular-
ized osteogenesis
Introduction
There is a clinical need for tissue-engineered cellular constructs for re-
construction of large skeletal defects [1]. Approximately 1.5 million
Americans every year suffer from bone loss that requires grafting to
bridge the gap [2]. Patients with large traumatic skeletal injuries un-
dergo multiple costly operations followed by rehabilitation mainly
due to insufficient mechanical stability, lack of vascularity and
inadequate resorption of the graft [3]. Autograft bone is the gold stan-
dard for reconstruction of bone defects [4]. However, there is insuffi-
cient source of autograft bone for patients with large skeletal defects
[5]. The use of frozen or freeze-dried allogeneic bone increases the risk
of transmission of unknown pathogens [6, 7]. To this end, the overall
goal of this research was to engineer a bone-mimetic scaffold as a sub-
stitute for autograft in reconstruction of large bone defects.
VC The Author(s) 2019. Published by Oxford University Press. 89
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The natural bone matrix with its interconnected network of
microcanals and high apatite content provides mechanical stability,
osteoconductivity and a dense vascular network for exchange of
nutrients and oxygen [8–10]. Mechanical toughness of the cortical
bone is rooted in its high quantity of calcium phosphate (CaP) nano-
crystals deposited on aligned collagen fibrils [11, 12], which assem-
ble to form microtubular osteons [13]. The adjacent osteons are
connected in the transverse direction by Volkmann canals to uni-
formly supply the osseous tissue with nutrients and oxygen and re-
move waste [14]. The fusion of the microtubular osteons generates
the rigid and tough shell of the cortical bone. We previously showed
that nanofibers functionalized with CaP nucleating peptides served
as a template for nucleation and growth of CaP nanocrystals [15].
We further discovered that organic acids like citric acid significantly
increased CaP deposition on the fibers [16] to the extent found in
the natural dense bone [17]. Further, we demonstrated that relaxa-
tion and shrinkage of the nanofibers upon annealing can be used for
fusion and lamination of the microsheets [17].
Scaffold geometry, porosity, pore size and pore connectivity af-
fect transport of nutrients, scaffold rigidity and degradation, and
uniformity of bone formation [18, 19]. The ideal scaffold for regen-
eration of bone tissue should balance mechanical properties, nutri-
ent permeability and scaffold resorption [20–22]. Many techniques
such as freeze-drying, gas foaming, solvent casting/porogen leaching
and 3D printing have been used to generate porous scaffolds [23–
26]. However, the scaffolds fabricated using these techniques lack
the rigidity, pore architecture and interconnectivity of the natural
bone ECM. Therefore, there is a need to develop cellular scaffolds
that mimic the natural tissue microstructure of dense, load-bearing
cortical bone.
The objective of this work was to synthesize a rigid, resorbable
and osteoconductive scaffold for implantation in large bone defects
by mimicking the hierarchical structure of the cortical bone. The fol-
lowing approach was used to achieve the objective. CaP nanocrys-
tals were grown on aligned nanofiber microsheets generated by
electrospinning of a blend of high molecular weight (MW) poly(L-
lactide) (PLA) and a conjugate of low MW poly(DL-lactide)
(LMWPLA) with CaP-nucleating glutamic acid (GLU) peptide
(LMWPLA-GLU). The CaP-nucleated microsheets were laminated
around microneedles to form osteon-mimetic microtubes. A set of
the microtubes were assembled around a solid rod and the assembly
was annealed to fuse the microtubes and produce a cortical shell.
Next, an array of circular microholes were drilled on the outer sur-
face of the cortical shell to generate Volkmann-like microcanals in
the perpendicular direction to the lumen of microtubes to generate a
cortical bone-like scaffold. The scaffold was characterized with re-
spect to CaP content, compressive modulus, porosity, permeability,
resorption and the extent of osteogenesis and vasculogenesis with
human mesenchymal stem cells (hMSCs), endothelial colony-
forming cells (ECFCs) and nanogels (NGs) for timed-release of bone




PLA with weight-average MW of 90 kDa was from LACTEL
(Cupertino, CA). L-lactide (L) and glycolide (G) monomers were
from Ortec (Easley, SC). Poly(ethylene glycol) (PEG, Mw¼ 8 and
12 kDa), porcine skin gelatin (type A, 300 bloom), human VEGF, re-
combinant human BMP2, their enzyme-linked immunosorbent
assay (ELISA) kits, methacrylic anhydride (MA), acryloyl chloride
(AC), ninhydrin reagent and Alizarin red stain were from Sigma–
Aldrich (St. Louis, MO). 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP)
and citric acid (CA) were from VWR (West Chester, PA). The
Irgacure 2959 photoinitiator was from CIBA (Tarrytown, NY).
Bovine serum albumin (BSA) was from Jackson ImmunoResearch
(West Grove, PA). Dulbecco’s Modified Eagle’s Medium (DMEM)
was from Gibco BRL (Grand Island, NY). Full EGM-2 medium
(BulletKit), ascorbic acid (AA), b-glycerophosphate (bGP), dexa-
methasone (DEX) were from Lonza (Allendale, NJ). PECAM-1
(CD31) and bovine anti-rabbit IgG-FITC (secondary antibody) were
from Santa Cruz Biotechnology (Dallas, TX). Fetal bovine serum
(FBS) was from Atlas Biologicals (Fort Collins, CO). The
QuantiChrom calcium and alkaline phosphatase (ALP) assays were
from Bioassay Systems (Hayward, CA). The Quant-it PicoGreen as-
say was from Invitrogen (Carlsbad, CA). Human MSCs and ECFCs
were received from Lonza (Allendale, NJ) and Boston Children
Hospital (Boston, MA), respectively.
Materials synthesis
Acrylate-terminated LMWPLA (Ac-LMWPLA) with MW of
5.3 kDa and polydispersity index (PI) of 1.2 was synthesized and
characterized as we previously described [15, 27]. The amino acid
sequence Glu-Glu-Gly-Gly-Cys hereafter denoted by GLU peptide
was synthesized, conjugated to Ac-LMWPLA and the conjugate was
characterized as we previously described [15]. The average number
of peptides per GLU-LMWPLA conjugate was 1.3 [15]. PEG with
short L and G segments (PEG-LG) was synthesized, functionalized
with succinimide groups and purified as we previously described
[28, 29]. Gelatin methacryloyl (GelMA) was synthesized as previ-
ously described [28].
Production of cortical bone-like scaffolds
Aligned nanofiber microsheets were generated by electrospinning of
a solution of 8 wt% PLA and 1.5 wt% LMWPLA-GLU in HFIP as
we previously described [15, 30]. The average thickness of the PLA/
LMWPLA-GLU microsheets, hereafter denoted by NF, was 6mm
and the average diameter of the fibers was 200 6 60 nm [15]. Next,
the microsheets were incubated in a modified simulated body fluid
(SBF) containing 6 mM citric acid for CaP nucleation and growth as
we previously described [15, 16]. After CaP nucleation, the micro-
sheet volume was determined from the measurements of its thick-
ness and surface area. Apparent density was determined by dividing
the microsheet mass by its volume. The volume porosity (Pv) of the
microsheets was determined from the measurements of wet weight
(Ww), wet volume (Vw) and dry weight as we previously described
[31]. The degradation of microsheets was measured by incubation in
SBF at 37C as we previously described [15].
The following procedure was used to produce a cortical bone-
like scaffold. A CaP nucleated microsheet (5 cm in length by 1 cm in
width, Fig. 1a) was wrapped around a 21-gauge needle (0.81 mm
outside diameter, Fig. 1b) to form a microtubular structure. The
wrapped microsheet was annealed at 85C for 10 min to fuse the
laminated layers and produce an osteon-mimetic microtube. To pro-
duce a cortical bone scaffold, the CaP-nucleated microsheets were
individually wrapped around needles between 10 and 30 times but
unlike the previous procedure the microtube-needle assemblies were
not annealed separately. Instead, a set of the microtube-needle as-
semblies were assembled around a stainless steel rod (Fig. 1c) and
the bundle was placed inside an elastic rubber sleeve to firmly pack
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the microtubes around the rod (Fig. 1d). Next, the packed
microtube-rod assembly was annealed at 85C under vacuum for
45 min to fuse the microtubes. After cooling, the cylindrical rod
and needles were removed to produce a nanostructured cortical
bone-like scaffold with Haversian-like microcanals (Fig. 1e). Next,
an array of circular microholes 1 mm apart was drilled on the outer
surface of the cortical shell traversing the shell thickness to generate
Volkmann-like microcanals perpendicular to the Haversian-like
canals (Fig. 1f). The microholes were drilled with a scanning deep-
ultraviolet laser micro-drilling system (Precision MicroFab, Curtis
Bay, MD, USA). The array of Haversian- and Volkmann-like canals in
the cortical-like scaffold formed an interconnected network of micro-
canals for cell migration, diffusion of nutrients and oxygen, and micro-
vessel formation within the cortical scaffold. The calcium content,
calcium to phosphate elemental ratio (Ca/P) and CaP content of the
scaffolds were measured as we described previously [15, 32].
Mutilayer microsheets with 10 layers were used for the measurement
of compressive modulus using a rheometer in a uniaxial compressive
mode as we previously described [33].
Synthesis of BMP2- and VEGF-conjugated nanogels
BMP2 was conjugated to succinimide-terminated PEG-LG with
PEG MW of 8 kDa, L to PEG molar ratio of 6.4, G to PEG ratio of
2 and overall PEG-LG MW of 10.3 kDa (hereafter referred to as
P8I) as we previously described [28]. VEGF was conjugated to
succinimide-terminated PEG-LG with PEG MW of 12 kDa, L to
PEG ratio of 6.7, G to PEG ratio of 4.4 and overall PEG-LG MW of
15 kDa (hereafter referred to as P12II) as we previously described
[28]. BMP2 and VEGF proteins were conjugated to succinimide-
terminated PEG-LG macromer and the conjugates were assembled
into nanogels as we previously described [34]. The amount of conju-
gated BMP2 or VEGF was measured by ELISA as we previously de-
scribed [28]. The release kinetic of VEGF and BMP2 from P8I and
P12II NGs, respectively, is shown in Supplementary Fig. S1. VEGF
grafted to P12II NGs (VEGF-NGs) was released steadily in 10 days
whereas BMP2 grafted to P8I NGs (BMP2-NGs) was released in
21 days [28].
Release characteristics of BSA from the cortical scaffold
Ten laminated microtubes were fused to form a hollow cylinder
with inner diameter of 0.8 mm. The lumen of the fused microtubes,
with or without micro-drilling, was filled with 100 mg/ml solution
of BSA in PBS and both ends of the bundle were sealed to prevent
leakage. Next, the BSA-loaded fused bundles were placed in a 2-ml
centrifuge tube and incubated in 1 ml of PBS with orbital shaking.
The amount of BSA in the supernatant was measured with the nin-
hydrin reagent as we previously described [15, 35].
Cell culture
Human MSCs were cultured in basal MSC medium as we previously
described (passaged <5 times) [25]. Human ECFCs were cultured in
full EGM-2 medium supplemented with 20% FBS on 1% gelatin-
coated flasks as described previously (passaged <4 times) [36].
Culture of hMSCs on microsheets and microtubes
The surface of sterilized microsheets and microtubes was wetted by
immersion in basal medium for 1 h prior to cell seeding. Each micro-
sheet or microtube was injected with 5 ml of hMSC suspension
(5106 cells/ml) in basal medium resulting in a surface density of
1105 cells/cm2. After 24-h incubation, the medium was replaced
with osteogenic medium (basal medium supplemented with 100 nM
DEX, 50mg/ml AA, 10 mM ßGP) and cultured for up to 28 days.
Culture of hMSCs and ECFCs in the cortical scaffolds
A perfusion cell culture system was used to culture hMSCs/ECFC-
seeded cortical scaffolds. The cortical scaffolds were produced by fu-
sion of 25 microtubes with 8 mm outer diameter, 2.5 mm shell thick-
ness and 5 mm length. The lumina of the cortical scaffolds was
injected with a suspension of hMSCs and BMP2-NGs in a SPELA
gel precursor solution (Fig. 1g). The SPELA precursor solution
Figure 1. Schematic diagram for the production of a cortical bone-like scaffold. The CaP nucleated microsheets (a) were laminated around a needle to form an
osteon-mimetic microtube (b). A set of the microtubes (c) were firmly assembled around a cylindrical rod by placing the bundle inside an elastic rubber sleeve (d)
and annealed at 85C to fuse the microtubes (e). An array of microholes were drilled on the outer surface of the fused microtubes, the rod and needles were re-
moved to generate a cortical scaffold (f); the culture system consisting of a perfusion bioreactor containing the cell-seeded cortical scaffolds (g), a peristaltic
pump, and a reservoir for oxygenation of the culture medium (h)
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consisted of 200 mg SEPLA macromer, 4 mg Ac-GRGD cell
adhesion peptide and 7.5 mg Irgacure-2959 photo-initiator in PBS.
Next, hMSCs at a density of 5106 cells/ml and 20 mg BMP2-NGs
(1.2 lg BMP2) were suspended in 1 ml of sterile SPELA precursor
solution. A 1.5-mm diameter needle (G-20) was placed in the center
of the cortical scaffold and the resulting SPELA suspension was
injected in the scaffold lumen. The injected precursor solution was
crosslinked by UV irradiation as we previously described [33]. The
channel left behind after removal of the needle directed the flow of
culture medium through the cortical scaffold in the perfusion culture
system. Then, ECFCsþMSCs (1:1 ratio) at a density of 5l06 cells/
ml and 2 mg VEGF-NGs were added to the sterile GelMA precursor
solution (50 mg GelMA and 7.5 mg photo-initiator in 1 ml PBS).
The cortical scaffold was inserted inside a cylindrical Teflon mold
with 10 mm inside diameter. Next, the volume between the cortical
scaffold and Teflon mold was injected with the GelMA precursor so-
lution. Then, the suspension was crosslinked by UV irradiation as
we previously described [33] to form a thin layer of GelMA hydro-
gel (1 mm thickness) on the outer surface of the cortical scaffold
(Fig. 1g). After removing the Teflon mold, the cell-seeded cortical
scaffold was press-fitted into a silicone tube to yield the bioreactor
section of the perfusion culture system (Fig. 1h). A medium reservoir
for simultaneous perfusion of 32 cortical scaffolds was used to oxy-
genate the culture medium (Fig. 1h). The cell-seeded cortical scaf-
folds were perfused with a 50:50 mixture of vasculogenic and
osteogenic medium (without VEGF, BMP2 or DEX) for the first
10 days followed by osteogenic medium (without DEX or BMP2)
for the remaining 11 days.
Biochemical, mRNA, protein analysis and
immunofluorescent staining
The cell-seeded samples were evaluated with respect to DNA con-
tent, ALP activity, calcium content, mRNA expression of osteogenic
markers Runx2, osteocalcin (OC), and collagen type I (Col I),
mRNA expression of vasculognic markers VE-cadherin, von
Willebrand factor (vWF), and CD31, and protein expression of
CD31 as we previously described [25]. The forward and reverse pri-
mers for the osteogenic and vasculogenic markers are provided in
Supplementary Table S1 [28]. The mRNA fold difference in expres-
sion for the gene of interest was normalized against day 1 expression
as we previously described [25]. The hMSC-seeded microsheets
were immunofluorescent stained for OC and osteopontin (OP) as
we previously described [15].
Statistical analysis
All experiments were done in triplicate. Significant differences be-
tween experimental groups were evaluated using a two-way
ANOVA test with P-values < 0.05 as we previously described [25].
Results
Characterization of the microsheets, microtubes and
cortical scaffolds
Figure 2a shows SEM image of the aligned nanofibers of a micro-
sheet nucleated with 240 wt% CaP nanocrystals. The average size of
the fibers in Fig. 2a was 80 nm and the microsheet thickness was
20 lm. The elemental spectrum of the mineralized microsheets, mea-
sured by energy-dispersive X-ray spectroscopy (EDS) as described
previously [16], is shown in Supplementary Fig. S2. The images in
Fig. 2b and c show the osteon-mimetic microtubes (240 wt% CaP)
with wall thickness to outside radius of 0.7 and 0.35, respectively.
Figure 2d shows a cortical scaffold with inner and outer diameters
of 2 and 3.5 cm, respectively, produced from the fusion of 220 CaP-
nucleated microtubes (240 wt% CaP, 300mm inner diameter and
1 mm outer diameter). Figure 2e shows an array of microholes with
diameter of 80 lm and center-to-center distance of 1 mm on the
outer surface of the cortical scaffold after laser drilling. A higher
magnification of the microholes is shown in Fig. 2f.
The effect of incubation time of the microsheets in the modified
SBF with or without the addition of citric acid on CaP nucleation on
the nanofibers is shown in Fig. 3a. The addition of citric acid to the
modified SBF significantly increased CaP content of the microsheets
from 148 6 20 wt% based on the fiber weight to 239 6 30 wt% af-
ter 24-h incubation. Porosity of the microsheets decreased after
annealing (Fig. 3b). Porosity of the pristine (without CaP) micro-
sheets decreased from 80 6 15% before annealing to 30 6 3% after
annealing whereas the porosity of those microsheets with 240 wt%
CaP decreased from 42 6 5% to 8 6 2%. The porosity of the
Figure 2. (a) A microsheet with 20 lm thickness composed of aligned nanofib-
ers with average fiber diameter of 180 nm and 240 wt% CaP content; (b)
cross-sectional image of a microtube with wall thickness to outside radius ra-
tio of 0.7 and outside diameter of 350 lm; (c) cross-sectional image of a
microtube with wall thickness to outside radius ratio of 0.35 and outside di-
ameter of 350mm); (d) Cross-sectional image of a cortical scaffold with inner
and outer diameters of 2 and 3.5 cm, respectively, produced by fusion of 220
microtubes with inner and outer diameter of 300 mm and 1 mm, respectively;
(e) Side-view of a cortical scaffold with inner and outer diameters of 1 and
2 cm, respectively, produced by fusion of 105 microtubes with inner and outer
diameter of 300 mm and 1 mm, respectively; (f) Magnified side-view of the cor-
tical scaffold in (e) showing the array of microholes drilled on the outer sur-
face. The microholes which spanned the entire wall thickness were separated
by 1 mm and their average diameter was 80 lm
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annealed microsheets with 240 wt% CaP was close to that of the
natural cortical bone at 15% [37]. The density of microsheets with
zero and 240 wt% CaP before annealing was 0.3 6 0.1 and
1 6 0.2 g/cm3, respectively, which increased to 0.7 6 0.1 and
1.9 6 0.1 g/cm3, after annealing (Fig. 3c). BSA was used to assess the
permeability and interconnectivity of the cortical scaffold. The array
of microholes drilled on the outer surface of the cortical scaffold in-
creased the amount of BSA released from the lumen to the medium
from 26 6 3% before drilling to 96 6 3% after drilling (Fig. 3d).
The burst BSA release of 40% after 1 min incubation was related
to pore interconnectivity of the cortical scaffold as reported previ-
ously [38]. Compressive modulus of the mineralized microsheets in-
creased by 10-fold after annealing due to relaxation and
densification of the fibers (Fig. 3e). Compressive modulus of the
microsheets with 240 wt% CaP content before annealing was
0.25 6 0.15 MPa which increased to 2.5 6 0.4 MPa after annealing.
Compressive modulus of the cortical scaffolds increased from 0.15
6 0.02 to 0.98 6 0.12, 1.27 6 0.21 and 1.76 6 0.29 GPa when the
CaP content increased from 0 to 160, 180 and 240 wt%, respec-
tively (Fig. 3f). Compressive modulus of the scaffold with 240 wt%
CaP was close to the reported modulus of natural human cortical
bone at 5GPa [39].
Degradation of the mineralized microsheets and cortical
scaffolds
Mass loss of the CaP-nucleated microsheets with incubation in SBF
at 37C before and after annealing is shown in Fig. 4a and c, respec-
tively. The magnified version of Fig. 4a and c are shown in Fig. 4b
and d, respectively. For a given time point, mass loss of the CaP-
nucleated microsheets was significantly lower than the pristine
microsheets regardless of annealing. The pristine microsheets with-
out annealing completely degraded in 35 days whereas those after
annealing degraded in 80 days. The mass remaining for CaP-
nucleated microsheets without annealing after 120 days incubation
ranged from 50 to 80 wt% compared with 90–98 wt% for those
with annealing. CaP nucleation increased stability of the microsheets
in SBF with or without annealing, as shown in the magnified Fig. 4b
and d. Further, for a given CaP content and incubation time,
annealed microsheets showed higher stability in SBF compared with
those without annealing. In that regard, the mass remaining for the
microsheets with 240 wt% CaP after 120 days incubation was
75 6 5 wt% without annealing and 96 6 3 wt% with annealing.
Figure 3. (a) the Effect of incubation time of the microsheets in the modified
SBF with and without citric acid on CaP nucleation; The effect of CaP content
on porosity (b) and density (c) of the microsheets before and after annealing;
(d) the release profile of BSA from the fused microtubes before and after mi-
cro-drilling; (e) the effect of CaP content on the compressive modulus of the
microsheets before and after annealing; (f) the effect of CaP content on the
compressive modulus of the cortical scaffolds. There was a statistically signif-
icant difference between the CaP content, porosity, density, BSA release and
compressive modulus of ‘after annealing’ and ‘before annealing’ groups
Figure 4. Mass loss of the cortical scaffolds with incubation time in SBF with
120, 180 and 240 wt% CaP content before (a and b) and after (c and d) anneal-
ing; figures (b) and (d) represent the magnified versions of figures (a) and (c),
respectively. There was no difference in mass loss of the scaffolds with 240
and 180 wt% CaP as well as those with 120 and 180 wt% CaP. There was a sig-
nificant difference between the mass loss of scaffolds with 240 and 120 wt%
CaP. The mass loss of the scaffolds with 120, 180 and 240 wt% CaP was signif-
icantly lower than those with no CaP
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Osteogenic differentiation of hMSCs on the
microsheets and microtubes
Human mesenchymal stem cells were seeded on the microsheets
(MS) or in the lumen of the microtubes (MT) and cultured in osteo-
genic medium for 28 days. After a slight initial increase, DNA con-
tent of the samples decreased with osteogenic differentiation of
hMSCs (Fig. 5a). DNA content (Fig. 5a) and peak ALP activity
(Fig. 5b) of hMSCs seeded on the microsheets were different from
those seeded on the microtubes. The peak ALP activity of hMSCs on
the microsheets was 2580 6 130 IU/mg DNA after 14 days as com-
pared with 5270 6 680 IU/mg DNA on the microtubes. The extent
of mineralization and collagen content of hMSCs seeded on the
microsheets and microtubes increased steadily with incubation from
day 7–28 (Fig. 5c and d). The calcium content of hMSCs on the
microtubes at 630 6 40 mg/mg DNA after 28 days was higher than
the microsheets at 450 6 60 mg/mg DNA (Fig. 5c). The collagen
content of the microtubes at 980 6 130 lg/lg DNA after 28 days
was higher than the microsheets at 470 6 70 lg/lg DNA (Fig. 5d).
Osteocalcin (OC, Fig. 5e) and Col I (Fig. 5f) mRNA expressions of
hMSCs on the microsheets and microtubes increased steadily with
incubation time. Col I expression of hMSCs in the microtubes was
higher than those on microsheets (Fig. 5f). Immunofluorescent
images of hMSC-seeded microsheets after 28 days incubation in
osteogenic medium stained for OC and osteopontin (OP) are shown
in Supplementary Fig. S3.
Co-culture of hMSCs and ECFCs in the cortical scaffolds
DNA content, ALP activity, calcium content and mRNA expression of
osteogenic markers for the cortical scaffolds are shown in Fig. 6a–f.
Groups included cortical scaffolds with cells and with growth factors
in static culture (G1, blue curve), scaffolds with cells but without
growth factors in perfusion culture (G2, light blue curve) and scaffolds
with cells and with growth factors in perfusion culture as the experi-
mental group (G3, red). DNA content of all groups decreased with in-
cubation which was attributed to cell differentiation as we previously
reported (Fig. 6a) [28]. ALP activity of all groups increased and peaked
on day 14 and then decreased with incubation time (Fig. 6b). The peak
ALP activity of G1, G2, G3 groups was 42506 300, 30006 100 and
61406 200 IU/mg DNA, respectively. Interestingly, the cortical scaf-
folds with cells and with growth factors cultured in static mode (G1)
had higher ALP activity (as well as higher Runx2 expression in Fig. 6d)
than the scaffolds with cells but without growth factors cultured in per-
fusion mode (G2). Calcium content of all groups, as a measure of the
extent of mineralization, steadily increased with incubation time
(Fig. 6c). The calcium content of G3 group at 11206 80 mg/mg DNA
was higher than G1 and G2 groups at 10406 60 and 7206 80 mg/mg
Figure 5. DNA Content (a), ALP activity (b), calcium content (c), total collagen content (d), fold difference in mRNA expression of OC (e) and Col I (f) of hMSCs
seeded on the microsheets (MS, blue) or the microtubes (MT, red) and cultured in osteogenic medium for 28 days. The microsheets had a thickness of 20 lm and
composed of nanofibers with diameter of 180 nm nucleated with 240 wt% CaP. The microtubes had inside and outside diameters of 0.8 and 1.2 nm, respectively,
and nucleated with 240 wt% CaP. One star in the figures indicates a statistically significant difference (P< 0.05) between the two groups at a given time point.
Error bars correspond to means 6 1 SD for n¼3
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DNA, respectively. The mRNA expression of Runx2 transcription fac-
tor initially increased with incubation time for all groups, peaked at
day 14 and then decreased (Fig. 6d). The OC and Col I mRNA expres-
sion of all groups increased steadily with incubation time (Fig. 6e and
f). The cortical scaffolds with cells and growth factors in a perfusion
culture (G3) had highest Runx2, OC and Col I expressions among all
groups after 21 days of incubation.
The mRNA expression of vasculogenic markers VE-cadherin,
vWF, and CD31, and CD31 protein expression for the cortical scaf-
folds are shown in Fig. 7a–e. The mRNA expression of VE-cadherin,
vWF and CD31 of all groups increased with incubation time (Fig. 7a–
c). The cortical scaffolds with cells and growth factors in perfusion
culture (G3) had highest expression of vasculogenic markers among
all groups. CD31 protein expression of all groups (Fig. 7d and e) in-
creased with incubation time consistent with the mRNA expression of
vasculogenic markers (Fig. 7a–c). The CD31 protein expression of G3
group was highest among all groups. For example, after 10days incu-
bation, the normalized CD31 protein expression of G1, G2 and G3
groups was 0.4 6 0.06, 0.326 0.08 and 0.68 6 0.12, respectively.
Discussion
The pore connectivity and architecture affect uniformity of nutrient
and oxygen distribution in the scaffold [40, 41] as it was previously
shown that anisotropic microcanals in tissue scaffolds improved
bone ingrowth in vitro and in vivo [42]. Open and interconnected
network of pores was shown to be essential for homogeneous vascu-
larization [43, 44] and served as a guide for cell migration and bone
formation in the central part of the scaffold [45]. It was demon-
strated in a previous study that interconnected microcanals im-
proved the flow of medium, nutrient transport and cell seeding
efficiency in multilayer scaffolds [46]. Further, scaffolds with inter-
connected pores enhanced stability of the implant through mechani-
cal interlocking between the scaffold and surrounding tissue [8]. In
this work, we successfully used fusion of laminated microtubes and
laser micro-drilling to generate CaP-rich, cortical-like scaffolds with
interconnected microcanals in the axial and transverse directions.
Previous studies have shown a close correlation between the rate
of scaffold resorption and bone formation [33, 47]. Porous ceramic
scaffolds that displayed a progressive resorption concurrent with
new bone deposition showed improved bone healing upon implanta-
tion in a critical-size sheep tibial defect [47]. Based on previous
reports, it takes 12 weeks for a newly formed callus to become
load-bearing as patients undergoing alveolar bone reconstruction
have to wait a minimum of 12 weeks for the formation of load-
bearing bone on the regenerating membrane prior to implantation
[48, 49]. Further, the implanted scaffold should resorb with time
and transfer load to the newly formed tissue to reduce stress-
shielding [50]. The results in Fig. 4 show that resorptions of <5% in
Figure 6. DNA Content (a), ALP activity (b), calcium content (c), mRNA expression level of osteogenic markers Runx2 (d), OC (e) and Col I (f) for the cortical scaf-
folds with hMSC/BMP2-NGs in the lumen and MSCþEFCF/VEGF-NGs on the outer surface and cultured in the perfusion bioreactor. Groups included cortical scaf-
folds with cells and with growth factors in static culture (G1, blue curve), scaffolds with cells but without growth factors in perfusion culture (G2, light blue curve),
and scaffolds with cells and with growth factors in perfusion culture as the experimental group (G3, red). A star in the figures indicates a statistically significant
difference between G3 and other groups. Error bars correspond to means 6 1 SD for n¼ 3
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the first 12 weeks (load-bearing for 12 weeks) can be achieved with
CaP-rich cortical scaffolds whereas the CaP-deficient scaffolds
completely degraded in 12 weeks. For example, the cortical scaffolds
with 120, 180 and 240 wt% CaP lost <8%, <6% and <4% of their
initial weight, respectively, after 12 weeks of incubation in physio-
logical medium (Fig. 4).
We previously showed that hMSCþECFC/VEGF-NG seeded
microchannels within a matrix seeded with hMSC/BMP2-NGs in-
creased osteogenic and vasculogenic differentiation of the seeded
cells [28]. We further showed that localized and timed-release of
BMP2 and VEGF induced the production of paracrine signaling fac-
tors like basic fibroblast growth factor (bFGF), platelet-derived
growth factor (PDGF) and transforming growth factor-b (TGF-b) by
the cells, which led to the coupling of osteogenesis and vasculogene-
sis [28]. The results in Figs 6 and 7 show that hMSC/ECFC seeded
cortical scaffolds differentiated and expressed markers of osteogene-
sis and vasculogenesis even in the absence of BMP2 and VEGF (see
light blue curves in Figs 6 and 7). This was attributed to high CaP
content of the cortical scaffolds and paracrine signaling between
hMSCs and ECFCs enabled by the interconnected network of micro-
canals. As reported previously, CaP-rich matrices induce osteogenic
differentiation of hMSCs through phosphate-ATP-adenosine meta-
bolic signaling [51]. Further, the extent of osteogenic and vasculo-
genic differentiation of hMSCs and ECFCs in the cortical scaffolds
significantly increased with the addition of BMP2-NGs and VEGF-
NGs (compare red and light blue curves in Figs 6 and 7).
Furthermore, the extent of osteogenic and vasculogenic differentia-
tion of hMSCs and ECFCs in the cortical scaffolds in perfusion cul-
ture was slightly higher than those in static culture. Therefore, cell
differentiation and matrix deposition was somewhat limited by
nutrients and oxygen transport in the cortical scaffold in the static
culture.
Conclusions
In this work, CaP-nucleated, aligned nanofiber microsheets were
laminated around microneedles to form osteon-mimetic microtubes.
The microtubes were assembled around a solid rod and annealed
to form a cortical-like structure. The cortical-like structure was
laser-drilled with an array of microholes to form a cortical bone-like
scaffold with an interconnected network of Haversian- and
Volkmann-like microcanals. CaP content of the cortical scaffolds
reached 240% by weight of fibers which was close to that of the nat-
ural cortical bone. The high CaP content of the microsheets pro-
longed degradation of the cortical scaffolds which improved their
long-term stability. The microtubular structure and interconnected
network of microcanals increased transport of growth factors and
nutrients in the cortical scaffold. hMSC encapsulated SPELA
Figure 7. The mRNA expression level of vasculogenic markers VE-cadherin (a), vWF (b) and CD31 (c), Western-blot bands (d) and expression level (e) of CD31
protein for the cortical scaffolds with hMSC/BMP2-NGs in the lumen and MSCþEFCF/VEGF-NGs on the outer surface and cultured in the perfusion bioreactor.
Groups included cortical scaffolds with cells and with growth factors in static culture (G1, blue curve), scaffolds with cells but without growth factors in perfusion
culture (G2, light blue curve), and scaffolds with cells and with growth factors in perfusion culture as the experimental group (G3, red). A star in the figures indi-
cates a statistically significant difference between G3 and other groups. Error bars correspond to means 6 1 SD for n¼3
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hydrogel in the lumen of the cortical scaffolds and ECFCþhMSC en-
capsulated GelMA on the outer surface of the scaffolds stimulated
osteogenesis and vasculogenesis in perfusion culture in the absence
of morphogenetic factors. This was attributed to high CaP content
of the cortical scaffolds and paracrine signaling between hMSCs and
ECFCs via interconnected network of the scaffold’s microcanals.
Supplementary data
Supplementary data are available at REGBIO online.
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